SEATTLE, June 9, 2009 (GLOBE NEWSWIRE) -- Ventus Medical, a privately-held medical device company focused on improving the lives of patients with sleep-disordered breathing, today announced that clinical data from three poster presentations presented at the SLEEP 2009 23rd Annual Meeting of the Associated Professional Sleep Societies further confirm PROVENT(r) Sleep Apnea Therapy’s clinical utility in treating mild, moderate and severe obstructive sleep apnea (OSA). SLEEP 2009 is being held June 8-11 in Seattle, WA.
